Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 137 clinical trials
Thrombectomy Device as Adjunctive Reperfusion Modality in ST-segment Elevation Myocardial Infarction (NATURE)

This study is designed to compare the safety and effectiveness of blood clot (thrombus) removal in subjects presenting with ST-segment elevation myocardial infarction (STEMI) with the enVast

  • 0 views
  • 23 Dec, 2021
  • 1 location
Clinical Study of CMR to Evaluate the Effect of Ivabradine on the Improvement of Left Ventricular Remodeling in STEMI Patients After Primary PCI

This study aim to investigate the effect of ivabradine on reducing infarct size and improving left ventricular remodeling after in patients undergoing primary PCI for ST-elevation myocardial infarction through myocardial enhanced MRI.

myocardial infarction
infarct
angiography
  • 0 views
  • 15 May, 2022
  • 1 location
Remote Ischemic Conditioning With Local Ischemic Postconditioning in High-Risk ST-elevation Myocardial Infarction (RIP-HIGH)

The RIP-HIGH trial is a two-arm randomized controlled trial aiming to compare the impact of combined remote ischemic conditioning (RIP) and local ischemic postconditioning (PostC) vs. standard of care on clinical outcome in high-risk ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention.

diuretics
ischemia
percutaneous coronary intervention
chest pain
left bundle branch block
  • 0 views
  • 11 Apr, 2022
  • 7 locations
The MOCA I Study - Microvascular Obstruction With CoFI™ System Assessment (MOCA)

resistance (dMVR) and microvascular obstruction (MVO) as measured by MRI in patients presenting with acute ST-elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI).

tirofiban
cangrelor
stemi
prasugrel
percutaneous coronary intervention
  • 0 views
  • 23 Mar, 2022
  • 3 locations
Evaluation of Myocardial Reperfusion After Primary PCI in Patients With High Platelet Reactivity Treated by Cangrelor or Not

This study aims to evaluate the impact on myocardial reperfusion and residual thrombotic burden of adding Cangrelor -a potent and immediate P2Y12 inhibitor- to ticagrelor in primary PCI patients with high on ticagrelor platelet reactivity compared to standard of care with ticagrelor alone.

reperfusion therapy
stemi
enoxaparin
myocardial reperfusion
aspirin
  • 0 views
  • 07 Jul, 2021
  • 1 location
FFR Driven Complete Revascularization Versus Usual Care in NSTEMI Patients and Multivessel Disease

To compare FFR guided complete revascularization during the index procedure with usual care in non-STEMI patients with multivessel disease.

revascularisation
angiography
stemi
stenosis
ischemia
  • 0 views
  • 25 Jul, 2021
  • 7 locations
OCT Guided vs COmplete Pci in patieNts With sT Segment Elevation myocArdial infarCtion and mulTivessel Disease

STEMI patients with multivessel disease will be randomized to complete PCI versus PCI driven by high risk criteria of plaques evaluated with OCT

  • 0 views
  • 16 May, 2021
  • 6 locations
SONOthrombolysis in Patients With an ST-segment Elevation Myocardial Infarction With fibrinoLYSIS (SONOSTEMI-LYSIS) Trial (SONOSTEMILYSIS)

This study will assess the safety and feasibility of sonothrombolysis in the acute management of STEMI undergoing reperfusion therapy with systemic fibrinolysis as part of a pharmacoinvasive

depression
reperfusion therapy
stemi
  • 0 views
  • 04 Jun, 2022
  • 1 location
The Impact of Compound Danshen Dropping Pills (CDDP) on the Post-myocardial Infarction Ventricular Remodeling

-Elevation myocardial infarction(STEMI). 268 patients with acute anterior wall STEMI after primary Percutaneous Coronary Intervention (pPCI) are randomly assigned 1:1 to CDDP group(n=134) and control group(n

reperfusion therapy
stemi
cardiac death
myocardial infarction
percutaneous coronary intervention
  • 0 views
  • 19 Aug, 2021
  • 1 location
Treatment of Slow-flow After Primary Percutaneous Coronary Intervention With Flow-mediated Hyperemia

A total of 100 patients with ST-elevation myocardial infarction (STEMI) presenting slow-flow after primary-percutaneous coronary intervention (PPCI) will be randomized to pharmacologic treatment

infarct
stemi
st elevation myocardial infarction
myocardial infarction
percutaneous coronary intervention
  • 0 views
  • 30 Oct, 2021
  • 5 locations